Financing Markets Mixed, Equities Lag (ICIS Chemical Business Nov 27 – Dec 4, 2025)
Young & Partners reports on our analysis of the debt and equity financing markets for the first three quarters of 2025 and the future outlook for Chemical financings.
Chemical M&A Mixed, Sideways (ICIS Chemical Business Nov 21 – Nov 27, 2025)
Young & Partners reports on our analysis of the M&A markets for the first three quarters of 2025 and the future outlook for Chemical M&A.
Navigating Divergent Currents – Biopharma Review and Outlook (Pharmaceutical Executive, August 2025)
Young & Partners shares proprietary analysis of the M&A, stock market, and funding environment in Biotech and Pharma and the outlook for 2025.
The Chemical M&A Market Treads Water (August 12, 2025)
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have affected the Chemical M&A market in the first half of 2025 and the outlook.
Pharma and Biotech: M&A Review and Outlook
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have affected the Biotech and Pharma M&A market in the first half of 2025 and the outlook.
Peter Young Receives the Foreign Policy Association Medal
Peter Young, Chief Executive Officer of Young & Partners was awarded the Foreign Policy Association Medal Award at a dinner held at the Harvard Club of New York on June 26. Past recipients include the Honorable Michael Bloomberg, Mayor, New York City; Timothy Geithner, Chairman, Federal Reserve Bank of New York; Jean-Claude Trichet, President of the European Central Bank; Kevin Rudd, Prime Minister, Australia; Sheila C. Bair, Chairman, Federal Deposit Insurance Corporation, and Anne-Marie Slaughter, Dean, Woodrow Wilson School of Public and International Affairs, Princeton University, among others.
Chemical Stock Market and Funding in the First Quarter 2025 and Beyond
Young & Partners shares proprietary analysis and outlook of Chemical stock market and funding market in the first quarter of 2025 and the outlook for the rest of 2025.
Biotech and Pharma Stock Market and Funding in the First Quarter 2025 and Beyond
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have affected the Biotech and Pharma Stock Market and Funding in the first quarter of 2025 and the outlook.
Chemical M&A in the First Quarter 2025 and Beyond
Young & Partners shares proprietary analysis and outlook of Chemical M&A in the first quarter of 2025 and the outlook for the M&A market in the rest of 2025.
Biotech and Pharma M&A in the First Quarter 2025 and Beyond
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have affected the Biotech and Pharma M&A market in the first quarter of 2025 and the outlook.